CRTO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Criteo SA is not a strong buy right now for a Beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock has short-term technical strength, but analyst sentiment has weakened materially after guidance cuts, and there is no recent news or financial snapshot to confirm a durable fundamental turnaround. Given the user's impatience and preference for a clear entry, this is more of a wait-and-watch than an immediate purchase.
CRTO is trading at 18.3, just above the key pivot at 17.153 and near first resistance at 18.158, with MACD histogram positive and expanding, which supports near-term upside momentum. However, RSI_6 is elevated at 73.998, suggesting the stock is already stretched in the short term, and moving averages are converging rather than showing a strong, clean uptrend. The nearby resistance zone at 18.779 may cap upside in the near term, while support sits at 16.149.
No news was reported in the recent week, so there are no fresh event-driven catalysts. Technical momentum remains positive, with a rising MACD histogram and price holding above the pivot. Options positioning is bullish, and hedge funds and insiders are both neutral rather than net selling. There is also no recent congress trading activity to weigh negatively.
Analyst sentiment has deteriorated: Wells Fargo downgraded Criteo to Equal Weight and cut the target to $18 after Q1 results and a weaker Q2/full-year outlook, which is especially important because the stock is trading only slightly above that target. Morgan Stanley and Benchmark also lowered targets, showing a broad downward revision trend. There is no recent news to offset the negative guidance narrative, and the absence of financial snapshot data limits confidence in the growth story.
Latest quarter season is Q1 2026. The financial snapshot is unavailable due to a data error, but analyst commentary says Q1 results were in-line while Q2 revenue guidance was about 8% below expectations and full-year guidance was cut. That points to slowing growth expectations rather than accelerating fundamentals, which weakens the long-term buy case for a beginner investor.
Recent analyst trend is negative to mixed: Wells Fargo downgraded CRTO to Equal Weight with an $18 target, Morgan Stanley cut its target to $29 from $33 while staying Equal Weight, and Benchmark trimmed its target to $25 from $30 while keeping Buy. Stifel still has a Buy rating with a $29 target, but overall the direction of price targets is down. Wall Street is split, but the consensus tone has turned cautious after the company reported in-line Q1 results and lowered Q2/full-year guidance. That means the pros see valuation support and potential upside if execution improves, while the cons focus on weaker growth, guidance cuts, and U.S. customer challenges.
